Tivity health, inc. (TVTY)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

8,623

19,887

17,239

15,481

12,124

4,799

19,960

19,208

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations

-

-

-

-

-

-

-

-

-

-140

6,518

-3,673

-220

-5,224

49,075

-195,452

-33,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss)

-198,106

-

-

-

4,214

-

-

-

21,336

-

-

-

-

-

-

-

-

-

-

-

-2,913

-

1,974

-517

-9,596

-5,290

1,800

-1,102

-3,949

604

5,028

5,057

-2,665

-177,070

9,463

5,779

4,135

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization

14,763

28,409

9,700

9,084

3,582

1,206

1,204

1,134

1,123

911

857

796

793

973

4,995

12,578

12,746

12,756

12,238

12,218

12,643

-93,628

13,378

13,536

13,336

13,292

12,951

13,015

13,533

13,501

13,259

12,801

12,173

12,645

12,467

12,443

12,433

Amortization and write-off of deferred loan costs

1,212

1,231

183

2,173

900

51

51

528

522

569

1,072

730

516

564

542

549

554

1,039

495

494

492

465

465

462

463

589

613

248

235

207

207

1,435

435

463

477

477

477

Amortization of debt discount

1,095

1,118

2,204

0

389

0

0

2,096

2,044

2,060

2,030

1,980

1,931

1,946

1,920

1,872

1,826

1,840

1,813

1,769

1,726

1,739

1,715

1,673

1,630

1,643

1,497

0

0

-

-

-

-

-

-

-

-

Share-based employee compensation expense

824

3,566

6,009

6,898

2,359

1,184

1,663

1,840

1,410

1,639

1,657

1,916

1,446

2,171

10,044

2,896

2,427

2,930

1,742

3,417

2,380

2,482

2,309

1,859

1,699

1,909

1,749

1,921

1,537

1,719

1,922

1,336

1,394

2,443

2,275

2,276

2,252

Impairment of goodwill and intangible assets

199,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on sale of TPHS business

-

-

-

-

-

-

-

-

-

-

-

-134

-310

-

-190,946

-4,826

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in income from joint ventures

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-32

171

132

214

-20,443

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-16,031

-62,565

-300

6,434

4,355

1,673

8,558

8,164

7,090

13,390

8,790

9,783

8,972

13,071

-96,848

8,026

-191

2,130

-5,653

-8,460

6,067

-508

-3,132

18

-3,350

-

-

-

-

183

-7

52

-1,562

-844

29

-57

-2,700

Excess tax benefits from share-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

368

185

30

80

230

146

341

94

137

15

474

0

3

0

94

167

172

Decrease (increase) in accounts receivable, net

-16,665

6,876

-2,347

-27,369

31,123

130

-1,709

1,178

12,712

953

-1,412

-12,061

16,459

-6,493

15,426

-9,792

-7,471

-15,143

10,599

-7,465

-4,962

12,648

6,109

-3,817

23,190

4,086

3,428

-10,677

-15,936

6,358

9,261

-2,406

10,226

3,898

9,945

-4,482

-1,909

Decrease in inventory

-4,057

12,688

-6,056

-2,694

-6,025

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other current assets

-4,746

4,034

-2,551

-889

-168

-66

-788

1,281

-2,037

1,215

-1,166

-1,310

441

2,729

-2,219

-1,374

-1,955

-2,238

-1,267

945

-236

278

-2,807

229

711

736

-4,055

3,789

128

-2,205

962

283

-2,024

-564

842

-216

-7,022

Increase in accounts payable

12,612

-135

-4,045

-12,427

6,555

1,190

584

-953

-916

840

233

-2,817

1,337

322

402

-2,925

-1,175

3,967

-2,514

-996

4,791

-1,752

-4,340

-10,630

7,379

13,587

-2,752

-1,688

77

5,034

901

-1,928

-5,002

2,054

-2,672

4,866

-2,782

Decrease in accrued salaries and benefits

-4,852

4,200

-1,162

1,337

-767

312

-698

-921

-9,007

4,864

1,028

146

-12,099

4,401

-10,446

5,216

-227

5,717

-1,156

4,575

-9,937

6,569

85

3,095

-6,584

3,997

-1,687

-897

-7,193

1,474

-2,194

1,803

-14,063

5,429

-1,940

-2,173

-10,248

Increase in other current liabilities

5,501

-7,357

-5,872

-13,842

5,576

-567

-6,672

-3,378

-1,185

1,051

-5,219

-4,910

2,642

-6,393

2,305

1,276

-2,013

-4,548

5,238

7,091

-19,545

6,429

2,648

-3,881

21,794

-798

-691

-6,676

6,969

725

3,266

1,405

8,241

-6,724

438

1,157

7,805

Increase in deferred revenue

3,247

-1,543

3,070

-5,034

2,309

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

1,790

148

563

685

660

699

685

602

625

-40

-637

-703

-1,185

-1,783

-2,518

-1,390

-1,734

3,930

-4,330

43

1,297

1,760

1,238

1,079

6,469

1,324

-845

755

-851

-1,972

497

-1,301

-2,320

-388

-298

-1,165

707

Net cash flows provided by operating activities

47,023

-2,518

35,224

44,397

5,202

34,211

33,228

28,933

12,367

31,648

33,568

37,036

3,024

27,523

-14,157

24,625

7,610

25,677

9,840

27,156

1,831

19,779

13,008

10,202

9,109

20,163

12,466

12,870

26,029

17,307

12,182

22,783

-11,574

17,962

9,358

28,134

20,838

Cash flows from investing activities:
Acquisition of property and equipment

4,875

9,359

6,436

5,020

3,898

2,597

2,783

1,727

1,946

1,936

1,730

1,010

1,234

1,614

2,530

3,880

6,450

8,340

9,058

8,723

8,609

11,064

10,951

10,410

10,566

8,513

13,254

8,315

11,264

8,177

12,945

12,705

15,085

15,782

11,844

11,877

9,787

Investment in joint ventures

-

-

-

-

-

-

-

-

-

-

-

-

-

0

433

412

453

-194

1,625

1,625

2,825

1,625

2,175

1,625

1,625

-

-

-

-

-

-

-

-

-

-

-

-

Business acquisitions, net of cash acquired

-

0

0

0

1,062,818

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

0

250

262

275

270

301

264

286

271

314

294

285

-4,544

1,911

1,925

1,918

797

1,796

2,454

1,825

1,804

1,968

1,790

1,327

Net cash flows used in investing activities

-4,875

-9,359

-6,436

-5,020

-1,066,716

-2,597

-2,783

-311

-1,946

-1,936

-1,730

-1,010

-1,234

-1,614

-30,682

602

-7,178

-4,047

-10,984

-10,612

-11,720

-12,960

-13,440

-12,329

-12,476

-10,476

-15,165

-11,070

-13,182

-8,974

-14,741

-19,852

-16,910

-17,586

-37,335

-13,667

-11,114

Cash flows from financing activities:
Proceeds from issuance of long-term debt

160,325

106,725

105,300

125,020

1,274,925

80,075

159,675

5,275

8,400

42,750

56,275

164,450

109,975

119,175

154,190

110,801

131,500

111,525

157,500

153,106

150,850

116,376

125,850

117,675

107,225

38,050

86,175

123,425

105,200

101,676

84,199

454,100

115,575

89,199

147,275

83,229

119,918

Payments of long-term debt

123,000

95,850

130,600

180,745

167,134

101,613

257,707

5,423

8,793

48,139

92,449

193,031

115,465

141,927

131,286

117,818

136,084

129,503

160,667

166,581

141,086

123,553

124,408

130,219

103,335

68,494

207,128

127,174

127,078

105,040

86,035

454,052

91,228

96,097

98,195

99,753

123,445

Proceeds from non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

238

0

1,377

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments related to tax withholding for share-based compensation

2,795

3,269

329

793

342

7,679

685

504

894

2,683

732

181

885

2,737

4,414

335

213

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from share-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

368

185

30

80

230

146

341

94

137

15

474

0

3

0

94

167

172

Exercise of stock options

601

299

331

136

234

389

386

364

771

1,408

1,557

507

2,250

1,255

8,717

30

0

3

1,172

154

1,138

1,353

233

1,102

163

186

10,398

1,804

360

0

2,826

0

9

13

1,076

1,874

1,862

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

14,234

5,588

3,868

Deferred loan costs

-

0

0

0

30,189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

303

0

28

60

54

4,030

436

744

0

0

2,547

0

0

0

-40

40

Principal payments related to financing leases

152

-

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in cash overdraft and other

3,421

-114

-1,037

2,606

902

-2,477

2,544

-35

378

450

525

403

1,155

278

11,282

-13,326

4,600

643

386

138

481

6

-893

13,703

-1,589

422

-11,262

1,109

10,257

-5,889

2,281

-97

4,287

611

-1,931

1,931

-1,320

Net cash flows provided by financing activities

38,400

7,506

-26,335

-53,765

1,078,385

-31,305

-95,787

-323

-138

-6,214

-34,824

-30,304

-2,970

-23,956

38,065

-20,648

-197

-21,768

-1,371

-15,384

13,128

-5,936

812

2,313

2,634

-9,744

2,894

-1,178

-11,868

-9,238

3,745

-2,596

28,646

-6,274

34,085

-18,100

-6,721

Effect of exchange rate changes on cash

-

0

0

4

-16

-19

-10

-96

69

34

98

1,410

242

-1,078

279

-451

989

243

-985

353

-1,252

-826

-1,099

83

307

-174

369

-755

-354

93

63

-159

120

126

-427

252

269

Less: net (decrease) increase in discontinued operations cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,587

-362

-588

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

80,548

-4,371

2,453

-14,384

16,855

290

-65,352

28,203

10,352

23,532

-2,888

7,132

-938

875

-3,908

3,766

636

-290

-1,156

-824

1,987

404

-719

269

-426

-231

564

-133

625

-812

1,249

176

282

-5,772

5,681

-3,381

3,272

Assets acquired through capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-